Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy: A Randomized, Double-Blind Pilot Study

ARA 290 (a peptide designed to activate the innate repair receptor that arrests injury and initiates cytoprotection, antiinflammation and healing) reduces allodynia in preclinical neuropathy models. We studied the safety and efficacy of ARA 290 to reduce symptoms of small fiber neuropathy (SFN) in p...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Heij, Lara, Niesters, Marieke, Swartjes, Maarten, Hoitsma, Elske, Drent, Marjolein, Dunne, Ann, Grutters, Jan C, Vogels, Oscar, Brines, Michael, Cerami, Anthony, Dahan, Albert
Médium: Artigo
Jazyk:Inglês
Vydáno: ScholarOne 2012
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3563705/
https://ncbi.nlm.nih.gov/pubmed/23168581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2012.00332
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky